How Targeted Cancer Drugs Disrupt the Cell Cycle
PLOS: DNA Science
JUNE 22, 2023
According to the FDA , the wording of the ads comes from a ”research team of social psychologists.” The researchers tested the survivin blocker vorasidenib in 331 people. After passing safety tests, Gleevec worked so well that it set a new record for drug approval—10 weeks, on May 10, 2001.
52 
Let's personalize your content